A hypercalcemic nude rat model that completely mimics human syndrome of humoral hypercalcemia of malignancy
- 1 August 1988
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 43 (2) , 97-102
- https://doi.org/10.1007/bf02555154
Abstract
Tumors causing humoral hypercalcemia of malignancy (HHM) were implanted to athymic nude rats. In one of these rat models transplanted with uterine cancer (UCC), a complete reproduction of human HHM syndrome was achieved: hypercalcemia, hypophosphatemia with increased urinary phosphate and cyclic AMP excretion, and suppressed serum 1,25-dihydroxy-vitamin D (1,25(OH)2D) level. In another hypercalcemic nude rat model implanted with oral cavity cancer (OCC), all the features were similar except for markedly elevated serum 1,25(OH)2D. Hypercalcemia disappeared by surgical removal of the tumors in both models, confirming the humoral mechanisms for causing these features. Furthermore, in UCC tumor-bearing rats, hypophosphatemia, increased renal phosphate excretion, and reduced serum 1,25(OH)2D concentration were already present when these rats were only marginally hypercalcemic. These results raise the possibility that the changes in renal tubular phosphate handling and vitamin D metabolism in HHM are not secondary to hypercalcemia but are due to direct effects of the humoral factor(s) that cause this syndrome. Extracts of both tumors exhibited stimulation of cyclic AMP production in osteoblastlike cells, UMR 106, which could be almost completely inhibited by parathyroid hormone (PTH) antagonist, human PTH(3–34). By comparing the nature and characteristics of humoral factor(s) from UCC and OCC models, mechanisms responsible for causing these abnormalities can be explored. Thus, these nude rat models can be useful for elucidating the underlying mechanism of the development of HHM.Keywords
This publication has 26 references indexed in Scilit:
- Role of insulin in the stimulation of renal 25-hydroxyvitamin D3-1α-hydroxylase by phosphorus deprivation in ratsMetabolism, 1987
- Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancyJournal of Bone and Mineral Research, 1986
- Tumor products and the hypercalcemia of malignancy.Journal of Clinical Investigation, 1985
- The Hypercalcemia of CancerNew England Journal of Medicine, 1984
- Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.Journal of Clinical Investigation, 1983
- Tumor-Derived Growth Factor Increases Bone Resorption in a Tumor Associated with Humoral Hypercalcemia of MalignancyScience, 1983
- Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors.Journal of Clinical Investigation, 1983
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980
- An athymic nude mutation in the ratNature, 1978
- An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissueBiochemical Medicine, 1977